Maternal cardiac risks in pre-eclamptic patients

Area of Science:

• Cardiology
• Obstetrics
• Reproductive Medicine

Background:

• Pre-eclampsia (PE) is a significant pregnancy disorder with complex pathophysiology.
• Understanding the link between PE and maternal cardiac health is vital for improved patient outcomes.

Purpose of the Study:

• To investigate the association between pre-eclampsia and various maternal cardiac risk factors.
• To identify specific biomarkers indicative of cardiac risk in women with PE.

Main Methods:

• A cohort of 41 pregnant women, including 25 with PE and 16 controls, was analyzed.
• Serum levels of total cholesterol, HDL-C, TG, homocysteine, apoprotein A1, apoprotein B100, lipoprotein (a), hsCRP, and cystatin C were measured.
• LDL and VLDL cholesterol levels were calculated using the Friedwald equation.

Main Results:

• Women with PE exhibited significantly higher levels of triglycerides (TG), LDL-C, homocysteine, apoprotein B100, and cystatin C compared to the control group (p < 0.05).
• Lower levels of HDL-C and apolipoprotein A1 were observed in the PE group (p < 0.05).
• While hsCRP levels were elevated in PE patients, the difference was not statistically significant.

Conclusions:

• Elevated cardiac risk factors in women with PE suggest a potential contribution to its multisystemic effects.
• Monitoring cardiac risk factors in women diagnosed with PE is recommended during pregnancy and for long-term health surveillance.
• Further research is warranted to fully elucidate the mechanisms linking PE and cardiovascular pathology.